EMERGENCE OF TRIMETHOPRIM-RESISTANT ENTEROBACTERIA IN PATIENTS RECEIVING LONG-TERM CO-TRIMOXAZOLE FOR THE CONTROL OF INTRACTABLE URINARY-TRACT INFECTION